Intrauterine Insemination Devices Market Trends

  • Report ID: 4279
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Intrauterine Insemination Devices Market Trends

Growth Drivers

  • Increasing Incidence of PCOS– The Centers for Disease Control and Prevention (CDC) estimates that around 6% to 12% of women in the United States suffer from polycystic ovary syndrome, which amounts to roughly 5 million of them.

PCOS causes hyperandrogenism and oligo-anovulation that are directly associated with infertility. A large number of women suffer from PCOS across the globe. For instance, approximately 75% of women worldwide are living with infertility owing to PCOS. This is considered to be one of the main reasons for infertility in women and it is expected to increase the global intrauterine insemination devices market size.

  • Surge in Drug Abuse – Almost 11 million people around the world consume psychoactive drugs, as per the data collected by the World Health Organization (WHO). This causes infertility in many couples and is estimated to drive the intrauterine insemination devices market growth. It has been observed that extreme consumption of drugs can reduce the chance of having a baby by reducing fertility in both men and women.

  • Increment in Smoking Habits – In 2019, there were more than a billion smokers, according to a comprehensive study on worldwide smoking trends. This affects fertility and is predicted to increase the demand for artificial insemination. Smoking habits are scientifically proven that can make the process of conceiving a child quite complex since exposure to smoking can damage the reproductive system and harm the DNA in sperm.

  • Rise in the Number of Cancer Cases and Chemotherapy – Cancer treatments may lead to poor reproductive health. According to the National Cancer Institute, cancer incidence is calculated to be approximately 442 per 100,000 people globally every year. Chemotherapies have been observed to affect ovaries by making them stop releasing estrogen and eggs.

  • Higher Prevalence of Obesity – As of 2019, there were about 2500 million overweight people around the World. Obesity affects nearly 39% of the global population. This condition is predicted to boost the global intrauterine insemination devices market as obesity may lead to the inability to conceive. Additionally, 6% of women worldwide experience fertility struggles owing to obesity.

Challenges

  • Risk of Infection - There is a possibility of infection when using intrauterine insemination devices. For instance, if the bacteria present in the vagina reach the uterus during the insemination procedure, it can cause infection. The symptoms include pelvic pain, chills, and fever, and there can also be light vaginal bleeding. Hence, this factor is estimated to hamper the market growth over the forecast period.
  • Higher Costs Associated with the Treatment
  • Preference for Alternative Procedures

Intrauterine Insemination Devices Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

3.8%

Base Year Market Size (2023)

USD 41.52 Billion

Forecast Year Market Size (2036)

USD 67.43 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4279
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of intrauterine insemination devices is assessed at USD 42.94 Billion.

The intrauterine insemination devices market size was valued at USD 41.52 Billion in 2023 and is likely to reach USD 67.43 Billion by the end of 2036, expanding at around 3.8% CAGR during the forecast period i.e., between 2024-2036. Rise in the number of cancer cases, chemotherapy and the increasing incidence of PCOS are the major factors driving the market growth.

North America is expected to account for largest industry share by 2036, attributed to increasing incidence of infertility across the region.

The Cooper Companies, Inc., Cook Group Incorporated, Kitazato Corporation., Rocket Medical plc, Prince Medical SAS, Gynotec B.V., SURGIMEDIK Healthcare India Pvt. Ltd., MedGyn Products, Inc., Meditech Devices Pvt Ltd, Biorad Medisys Private Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample